Crossmark

Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience

Crossref DOI link: https://doi.org/10.1038/s41408-021-00579-0

Published Online: 2021-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cattaneo, Daniele https://orcid.org/0000-0002-7571-023X
Bucelli, Cristina

Cavallaro, Francesca

Consonni, Dario https://orcid.org/0000-0002-8935-3843
Iurlo, Alessandra https://orcid.org/0000-0002-4401-0812
License Information

Text and Data Mining valid from 2021-11-26

Version of Record valid from 2021-11-26
More Information

Article History

Received: 26 October 2021

Revised: 11 November 2021

Accepted: 12 November 2021

First Online: 26 November 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below